2018
DOI: 10.1016/j.bbr.2018.04.011
|View full text |Cite
|
Sign up to set email alerts
|

Reserpine-induced depression is associated in female, but not in male, adolescent rats with heightened, fluoxetine-sensitive, ethanol consumption

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 77 publications
0
6
0
Order By: Relevance
“…Reserpine is a vesicle reuptake inhibitor, which arrests the neurotransmitters (norepinephrine, epinephrine, dopamine and serotonin) reuptake process on the presynaptic membrane and, therefore, facilitates their further degradation by monoamine oxidase. The depletion of catecholamines (norepinephrine, epinephrine, and dopamine) and serotonin (5-HT) leads to morphological changes in the brain of tested animals and has good face validity due to the appearance of the depression-like phenotype [145][146][147][148]157]. This model is widely used in preclinical studies to evaluate the antidepressant effect of new developing drugs and plant compounds [149][150][151][152][153][154] due to the short-term time and good predictive validity [147,155].…”
Section: Pharmacological Models 431 Reserpine Induced Depression Modelmentioning
confidence: 99%
See 1 more Smart Citation
“…Reserpine is a vesicle reuptake inhibitor, which arrests the neurotransmitters (norepinephrine, epinephrine, dopamine and serotonin) reuptake process on the presynaptic membrane and, therefore, facilitates their further degradation by monoamine oxidase. The depletion of catecholamines (norepinephrine, epinephrine, and dopamine) and serotonin (5-HT) leads to morphological changes in the brain of tested animals and has good face validity due to the appearance of the depression-like phenotype [145][146][147][148]157]. This model is widely used in preclinical studies to evaluate the antidepressant effect of new developing drugs and plant compounds [149][150][151][152][153][154] due to the short-term time and good predictive validity [147,155].…”
Section: Pharmacological Models 431 Reserpine Induced Depression Modelmentioning
confidence: 99%
“…The depletion of catecholamines (norepinephrine, epinephrine, and dopamine) and serotonin (5-HT) leads to morphological changes in the brain of tested animals and has good face validity due to the appearance of the depression-like phenotype [145][146][147][148]157]. This model is widely used in preclinical studies to evaluate the antidepressant effect of new developing drugs and plant compounds [149][150][151][152][153][154] due to the short-term time and good predictive validity [147,155]. However, reserpine treatment produces motor impairments mimicking Parkinson disease dyskinesia, increased nociceptive sensitization and hypothermia and has high mortality rate [148,[155][156][157].…”
Section: Pharmacological Models 431 Reserpine Induced Depression Modelmentioning
confidence: 99%
“…Recently, it was reported that reserpine-induced depression is associated with heightened, fluoxetine-sensitive, ethanol consumption in female, but not in male, adolescent rats. Thus, this model is currently used to explore the relationship between depression in adolescent females and alcohol consumption [25].…”
Section: Depression Modeling Approachesmentioning
confidence: 99%
“…In humans, treatment with fluoxetine is effective in reducing symptoms of obsessive-compulsive disorder in adults, adolescents and children [ 85 , 86 , 87 ]. On the other hand, fluoxetine has been demonstrated to be effective in reducing ethanol consumption in female rats [ 88 ] and rats with a high preference for alcohol [ 89 ]. In humans, it has also been effective in reducing alcohol consumption in adults [ 90 ].…”
Section: Discussionmentioning
confidence: 99%